Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.540
-0.050 (-3.14%)
At close: Aug 13, 2025, 4:00 PM
1.550
+0.010 (0.65%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $62.75 million as of August 14, 2025. Its market cap has decreased by -77.04% in one year.
Market Cap
62.75M
Enterprise Value
35.35M
1-Year Change
-77.04%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $62.75M, a decrease of -95.29%. That is a compound annual growth rate of -46.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 62.75M | -76.60% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 590.13B |
| Johnson & Johnson | 419.87B |
| AbbVie | 355.54B |
| UnitedHealth Group | 244.86B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.95B |
| Novo Nordisk | 223.00B |